NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Conditions: Ovarian Carcinoma; Fallopian Tube Carcinoma; Peritoneal Carcinoma; Endometrial Cancer; Adenocarcinoma of Lung; Triple Negative Breast Cancer; Liposarcoma; Leiomyosarcoma; Mesothelioma, Malignant; Adenocarcinoma - Gastroesophageal Junction (GEJ); Adenocarcinoma of the Stomach; Melanoma, Malignant; Renal Cell Carcinoma Interventions: Biological: NM32-2668 Sponsors: Numab Therapeutics AG Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Asbestosis | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Endometrial Cancer | Fallopian Tube Cancer | Gastric (Stomach) Cancer | Gastroenterology | Kidney Cancer | Leiomyosarcoma | Liposarcoma | Melanoma | Mesothelioma | Ovarian Cancer | Ovaries | Renal Cell Carcinoma | Research | Skin Cancer